The Role of Interleukin-10 in Susceptibility of BALB/c Mice to Infection with Leishmania Mexicana and Leishmania Amazonensis
Overview
Affiliations
Recent studies have demonstrated the critical role of IL-10 in susceptibility to cutaneous and visceral leishmaniasis caused by Leishmania major and Leishmania donovani, respectively. To determine whether IL-10 also plays a similar role in the susceptibility and pathogenesis of cutaneous leishmaniasis caused by the New World species, L. mexicana and L. amazonensis, we analyzed their course of infection in IL-10-deficient BALB/c mice and their wild-type counterparts. Although IL-10-deficient mice infected with either L. mexicana or L. amazonensis failed to control the lesion progression, we did observe consistently lower levels of infection in IL-10(-/-) mice compared with wild-type BALB/c mice. We also observed increased IFN-gamma and NO production and higher levels for IL-12p40 and IL-12Rbeta(2) mRNA in cells from IL-10(-/-) mice compared with cells from BALB/c mice. The mRNA levels for IL-4, which increased significantly in both IL-10(-/-) and BALB/c mice, were comparable. When treated with anti-IL-4 mAb, IL-10(-/-) mice resolved the infection more effectively and had significantly fewer parasites in their lesions compared with similarly treated BALB/c mice. These findings suggest that IL-10, although not the dominant mediator of susceptibility of BALB/c mice to infection with L. mexicana and L. amazonensis, does play a significant role in regulating the development of a protective Th1-type response. However, effective resolution of infection with these New World parasites requires neutralization of both IL-4 and IL-10.
promotes pain-reducing metabolomic reprogramming in cutaneous lesions.
Volpedo G, Oljuskin T, Cox B, Mercado Y, Askwith C, Azodi N iScience. 2023; 26(12):108502.
PMID: 38125023 PMC: 10730346. DOI: 10.1016/j.isci.2023.108502.
Diupotex M, Zamora-Chimal J, Gajon J, Bonifaz L, Becker I Front Immunol. 2023; 14:1231836.
PMID: 37691941 PMC: 10485697. DOI: 10.3389/fimmu.2023.1231836.
Centrin-deficient Leishmania mexicana confers protection against Old World visceral leishmaniasis.
Karmakar S, Volpedo G, Zhang W, Lypaczewski P, Ismail N, Oliveira F NPJ Vaccines. 2022; 7(1):157.
PMID: 36463228 PMC: 9719514. DOI: 10.1038/s41541-022-00574-x.
Impact of collaborative actions of subpopulations on the infection profile.
Albuquerque-Melo B, Cysne-Finkelstein L, Goncalves-Oliveira L, Cascabulho C, Henriques-Pons A, Pereira M Parasitology. 2022; 149(12):1526-1535.
PMID: 35822537 PMC: 11010534. DOI: 10.1017/S003118202200097X.
Centrin-deficient Leishmania mexicana confers protection against New World cutaneous leishmaniasis.
Volpedo G, Pacheco-Fernandez T, Holcomb E, Zhang W, Lypaczewski P, Cox B NPJ Vaccines. 2022; 7(1):32.
PMID: 35236861 PMC: 8891280. DOI: 10.1038/s41541-022-00449-1.